Yekaterina Chudnovsky
Direktor/Vorstandsmitglied bei ELICIO THERAPEUTICS, INC.
Vermögen: 7 Mio $ am 30.04.2024
Aktive Positionen von Yekaterina Chudnovsky
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ELICIO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.10.2022 | - |
| Independent Dir/Board Member | 01.10.2022 | - | |
| IMMIX BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 22.08.2023 | - |
| Independent Dir/Board Member | 22.08.2023 | - | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - | - |
xCures, Inc.
 xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Direktor/Vorstandsmitglied | - | - |
| Gkcc LLC | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Yekaterina Chudnovsky
Ausbildung von Yekaterina Chudnovsky
| Northwestern University | Undergraduate Degree |
| DePaul University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IMMIX BIOPHARMA, INC. | Health Technology |
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
xCures, Inc.
xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Technology Services |
| Gkcc LLC |
- Börse
- Insiders
- Yekaterina Chudnovsky
- Erfahrung
